Preclinical safety and efficacy of cannabidivarin for early life seizures.

georgetown.edu.Abstract A significant proportion of neonatal and childhood seizures are poorly controlled by existing anti-seizure drugs (ASDs), likely due to prominent differences in ionic homeostasis and network connectivity between the immature and mature brain. In addition to the poor efficacy of current ASDs, many induce apoptosis, impair synaptic development, and Read more…

Partage le savoir
error: Content is protected !!